Related Experiment Video
Updated: Sep 25, 2025

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
A tale of antiviral counterattacks in rotavirus infection
Arkadeb Bhuinya1, Debashree Dass1, Anwesha Banerjee1
1Division of Virology, ICMR-National AIDS Research Institute, Pune, MH, India.
Insights
New antiviral drugs derived from natural sources show promise against human rotavirus (HRV) gastroenteritis in children. These RNA-silencing therapies target host and viral factors to combat HRV infection, addressing a critical gap in treatment options.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Human rotaviruses (HRV) are a leading cause of severe infantile gastroenteritis globally.
- Existing rotavirus vaccines are effective but do not address treatment for infected individuals.
- There is a significant unmet need for approved antiviral agents against rotavirus infections.
Purpose of the Study:
- To review recent advancements in naturally derived, RNA-silencing-based drug substances for treating rotavirus infections.
- To explore the mechanisms by which these agents exhibit anti-rotaviral activity.
- To highlight their potential in combating rotavirus pathogenesis.
Main Methods:
- Literature review of recent studies on RNA-silencing therapies and natural product-derived antivirals.
- Analysis of research focusing on host and viral targets of anti-rotaviral agents.
- Synthesis of information on the development and efficacy of novel therapeutic strategies.
Main Results:
- Naturally derived RNA-silencing agents demonstrate significant anti-rotaviral activity.
- These therapies effectively target critical host and/or viral factors involved in rotavirus replication and pathogenesis.
- Early research indicates potential for these agents as novel therapeutic interventions.
Conclusions:
- RNA-silencing-based drugs derived from natural sources represent a promising avenue for rotavirus treatment.
- Targeting host and viral factors offers a versatile strategy to combat rotavirus gastroenteritis.
- Further development of these agents could address the current lack of effective antiviral therapies for rotavirus infections.
Abstract:
Human rotaviruses are the utmost etiologic agents of infantile gastroenteritis in children under five years of age. To reduce childhood morbidity and mortality caused by this rotavirus infection, numerous efforts are being made worldwide in the form of better and universal immunisation programmes. Though few vaccines are in action, the lack of approved antiviral agents that have potential combative effects against the rotavirus infection in the host, remains a point of concern. This review focuses on recent insights into the development of naturally derived, RNA-silencing-based drug substances that show their anti-rotaviral activities by targeting and influencing different host and/or viral factors that contribute directly or indirectly to successful viral pathogenesis.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Retrovirus Life Cycles
Viral Mutations
Retroviruses
Subviral Agents
Viruses with RNA Genomes

